Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Gut|October 1, 1994
Impaired oesophageal transit of capsule versus tablet formulations in the elderlyA C Perkins, C G Wilson, P E Blackshaw, et al.Pharmaceutical Research|April 2, 1998
Risedronate gastrointestinal absorption is independent of site and rate of administrationD Y Mitchell, R A Eusebio, L E Dunlap, et al.Plos One|September 3, 2011
Immunoproteasome-deficiency has no effects on NK cell education, but confers lymphocytes into targets for NK cells in infected wild-type miceMary J G van Helden, Natascha de Graaf, Cornelis P J Bekker, et al.Journal of Virology|October 10, 2008
Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanningMonique Oostra, Marne C Hagemeijer, Michiel van Gent, et al.International Journal of Pharmaceutics|September 16, 1999
Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulationsA C Perkins, C G Wilson, M Frier, et al.Veterinary Research|July 29, 2010
Pathogenic characteristics of persistent feline enteric coronavirus infection in catsLiesbeth Vogel, Mariken Van der Lubben, Eddie G te Lintelo, et al.Plos One|February 16, 2018
Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndromeAna P Lopes, Maarten R Hillen, Eleni Chouri, et al.Rheumatology (Oxford, England)|June 7, 2018
microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndromeLucas L van den Hoogen, Marzia Rossato, Ana P Lopes, et al.Frontiers in Immunology|August 20, 2021
The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating MediatorsAna P Lopes, Cornelis P J Bekker, Maarten R Hillen, et al.Experimental Dermatology|March 17, 2022
Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseasesNanette L A Vincken, Paco M J Welsing, Sandra C Silva-Cardoso, et al.Pageof 6